Madrigal Pharmaceuticals, Inc. Share Price
Stocks
MDGL
US5588681057
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
01:30:00 19/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 524.37 USD | -0.10% |
|
-2.04% | -9.95% |
| Market Cap | 1.21TCr 1.05TCr 985.45Cr 895.64Cr 1.68TCr 1,16200Cr 1.71TCr 12TCr 4.53TCr 58TCr 4.55TCr 4.45TCr 1,93600Cr | P/E 2026 * |
-83.1x | P/E 2027 * | 83.4x |
|---|---|---|---|---|---|
| Enterprise Value | 1.16TCr 1TCr 942.82Cr 856.9Cr 1.61TCr 1,11200Cr 1.64TCr 11TCr 4.33TCr 56TCr 4.36TCr 4.26TCr 1,85200Cr | EV / Sales 2026 * |
7.6x | EV / Sales 2027 * | 5.21x |
| Free-Float |
94.13% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Madrigal Pharmaceuticals, Inc.
| 1 day | -0.10% | ||
| 1 week | -2.04% | ||
| Current month | +12.21% | ||
| 1 month | -2.11% | ||
| 3 months | +0.41% | ||
| 6 months | +6.69% | ||
| Current year | -9.95% |
| 1 week | 494.9 |  | 544.49 |
| 1 month | 447.01 | | 566.18 |
| Current year | 416.21 | | 598.79 |
| 1 year | 374.5 | | 615 |
| 3 years | 119.76 | | 615 |
| 5 years | 52.33 | | 615 |
| 10 years | 8.74 | | 615 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Sibold
CEO | Chief Executive Officer | 59 | 08/09/2023 |
Mardi Dier
DFI | Director of Finance/CFO | 62 | 11/03/2024 |
David Soergel
CTO | Chief Tech/Sci/R&D Officer | 58 | 21/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Rebecca Taub
BRD | Director/Board Member | 74 | 01/07/2016 |
Richard Levy
BRD | Director/Board Member | 68 | 11/08/2016 |
James Daly
BRD | Director/Board Member | 64 | 27/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/07/26 | Sell | Chief Executive Officer | -2,500 | 0.0108% | ||
| 17/06/26 | Free | Director | 1,220 | 0.0053% | ||
| 23/02/26 | Fiscal year | Director | 5,000 | 0.0220% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.10% | -2.04% | +33.96% | +191.74% | 1.21TCr | |
| +0.17% | +3.62% | +70.94% | +109.68% | 7.33TCr | |
| +1.73% | +13.43% | +57.10% | +90.54% | 6.2TCr | |
| +0.11% | -3.10% | +0.94% | +491.16% | 2.8TCr | |
| +5.24% | +5.33% | +57.01% | +17.77% | 2.41TCr | |
| +1.26% | -0.05% | -17.59% | -15.96% | 2.3TCr | |
| -0.71% | +5.26% | +241.94% | +427.03% | 1.83TCr | |
| 0.00% | +5.62% | +40.50% | -15.26% | 1.95TCr | |
| +3.83% | +2.65% | +25.00% | +592.85% | 1.59TCr | |
| +1.53% | +3.49% | +40.68% | +151.75% | 1.3TCr | |
| Average | +1.24% | +1.30% | +55.05% | +204.13% | 2.89TCr | |
| Weighted average by Cap. | +1.16% | +3.37% | +56.35% | +168.52% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 152.63Cr 131.83Cr 124.03Cr 112.73Cr 212.02Cr 15TCr 215.13Cr 1.45TCr 570.18Cr 7.31TCr 573.05Cr 560.61Cr 24TCr | 214.49Cr 185.25Cr 174.3Cr 158.41Cr 297.95Cr 21TCr 302.32Cr 2.04TCr 801.26Cr 10TCr 805.3Cr 787.82Cr 34TCr |
| Net income | -18Cr -16Cr -15Cr -14Cr -26Cr -1.76TCr -26Cr -175.27Cr -69Cr -881.1Cr -69Cr -68Cr -2.93TCr | 20Cr 17Cr 16Cr 15Cr 28Cr 1.92TCr 28Cr 190.64Cr 75Cr 958.38Cr 75Cr 73Cr 3.19TCr |
| Net Debt | -52Cr -45Cr -43Cr -39Cr -73Cr -5.03TCr -74Cr -499.99Cr -195.95Cr -2.51TCr -196.93Cr -192.66Cr -8.37TCr | -94Cr -81Cr -77Cr -70Cr -131.03Cr -9.04TCr -132.95Cr -899.11Cr -352.36Cr -4.52TCr -354.13Cr -346.44Cr -15TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/26/19 | $524.37 | -0.10% | 3,56,137 |
| 17/26/17 | $524.87 | +3.41% | 3,07,441 |
| 14/26/14 | $507.56 | +0.04% | 2,34,655 |
| 13/26/13 | $507.37 | -5.38% | 2,77,891 |
| 12/26/12 | $536.20 | +0.17% | 2,85,551 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MDGL Stock
Select your edition
All financial news and data tailored to specific country editions
